Lifecore Biomedical (NASDAQ: LFCR) revenue
Lifecore Biomedical reported revenue of $128.9m for fiscal 2025, 0.5% more than in fiscal 2024 ($128.3m). Since fiscal 2016 its revenue has fallen by 73.0%, an average decline of 13.5% a year.
Lifecore Biomedical has grown its revenue for 2 years in a row, and its best year of the last 10 was fiscal 2019. The biggest drop was in fiscal 2020, −71.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $128.9m | +0.5% | −$17.2m | −13.4% |
| 2024 | $128.3m | +24.2% | −$8.8m | −6.9% |
| 2023 | $103.3m | −7.2% | −$21.8m | −21.1% |
| 2022 | $111.3m | +10.3% | −$11.8m | −10.6% |
| 2021 | $100.9m | −37.0% | −$8.8m | −8.7% |
| 2020 | $160.1m | −71.3% | −$25.9m | −16.2% |
| 2019 | $557.6m | +6.4% | $5.5m | 1.0% |
| 2018 | $524.2m | +11.6% | $13.6m | 2.6% |
| 2017 | $469.8m | −1.5% | $14.7m | 3.1% |
| 2016 | $476.9m | — | −$20.6m | −4.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Lifecore Biomedical revenue compared with its sector
By revenue for its latest fiscal year, Lifecore Biomedical ranks 272nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Lifecore Biomedical, 0.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 270th | NRC Health | $137.4m | −4.0% |
| 271st | RxSight | $134.5m | −3.9% |
| 272nd | Lifecore Biomedical | $128.9m | 0.5% |
| 273rd | Xencor | $125.6m | 13.7% |
| 274th | Monte Rosa Therapeutics | $123.7m | 63.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Lifecore Biomedical
- How much revenue did Lifecore Biomedical make in fiscal 2025?
- Lifecore Biomedical reported revenue of $128.9m for fiscal 2025, compared with $128.3m in fiscal 2024.
- How much has the revenue of Lifecore Biomedical fallen?
- Between fiscal 2016 and fiscal 2025 it went from $476.9m to $128.9m: 73.0% less, an average decline of 13.5% a year.
- What was the best year for revenue at Lifecore Biomedical?
- Of its last 10 fiscal years, fiscal 2019, with $557.6m.
- Where does Lifecore Biomedical rank in its sector by revenue?
- It ranks 272nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Lifecore Biomedical come from?
- From the annual report (Form 10-K) that Lifecore Biomedical files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Lifecore Biomedical files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Lifecore Biomedical: the Lifecore Biomedical page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.